Clinical Trials Browser

Phase 1 × Withdrawn × parsaclisib × Clear all

NCT05867030 2023-10-17

Parsaclisib in Patients With Relapsed or Refractory Follicular Lymphoma

Phase 1 Withdrawn

Lymphoma, Follicular

NCT04142554 2020-11-03

LCCC1820

Phase 1 Withdrawn

Breast Neoplasms, Triple Negative Breast Neoplasms